Trademark Overview
On Thursday, December 4, 2025, a trademark application was filed for RESISTANCE360 with the United States Patent and Trademark Office. The USPTO has given the RESISTANCE360 trademark a serial number of 99530014. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, December 4, 2025. This trademark is owned by ConcertAI LLC. The RESISTANCE360 trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:
Downloadable software to collect and analyze healthcare data and information; Downloadable computer software data application platform to store and analyze patient data in the healthcare industry; Downloadable enterprise software in the nature of databases and electronic data sets containing data relating to healthcare
Software as a service (SAAS) services featuring software for use in the collection and analysis of healthcare data and healthcare information; Platform as a service featuring computer software platforms, namely, data application platform to store and analyze patient data in the healthcare industry; Computer services, namely, providing computer software as a service (SaaS) featuring software for identifying, collecting, managing, analyzing, segmenting, retrieving, monitoring, maintaining, reporting on, structuring, modeling, forecasting, presenting and displaying healthcare data and healthcare information; Computer services, namely, providing platforms as a service (PaaS) featuring computer software for creating web applications, data storage and backup, database management, virtualization, networking, collaboration, information access, customer service and support, cloud computing, data sharing, data security, all in the field of healthcare data and healthcare information; Computer ser...
Business services provided to the healthcare industry, namely, evaluation of testing results, patient identification services, testing assessment services, treatment selection services, treatment assessment services, outcome assessment services, clinical trial development services, research study development services, standard of care development services, and data analysis services; Business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposes; Collection and analysis of quality clinical and empirical data for a network of health care providers for business purposes; none of the foregoing services in the fields of genetics, genetics testing, or business analytics of genetics testing
